Uta Griesenbach is a Professor in Molecular Medicine at the National Heart and Lung Institute, Imperial College London and the President of the British Society for Gene and Cell Therapy (www.bsgct.org/). Uta‘s reserach interests are related to the development of gene therapy-based treatments for cystic fibrosis and other inflammatory lung diseases and include vector and biomarker development, toxicology and safety as well as GMP-vector production. Uta is Co-Investigator on several gene therapy trials, including a recently completed non-viral Phase IIb study. Uta is a Strategy Group Member of the UK Cystic Fibrosis Gene Therapy Consortium (www.cfgenetherapy.org.uk/) and is the Gene Therapy advisor (GTAC) on the West London National Research Ethics Comittee. In addition, Uta is interested in teaching and work-force development. She is Deputy-director for post-graduate reserach at the National Heart and Lung Institute and Programme director for the MSc in Genes, Drugs and Stem cells-Novel Therapies at Imperial College.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.